Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Indian HoFH Patients (RAMAN)
NCT03403374Phase 4Completed
- Sponsor
- Amgen
- Start
- Aug 2018
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in familial hypercholesterolemia (FH), sponsored by Amgen. Started Aug 2018; status: completed.
02
Drugs
evolocumab
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT03403374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03403374.